Akdital completes Mecca deal: analysts target Akdital stock at MAD 1,680

Published on 10/14/2026 at 03:39 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

First-half 2026 revenue reached MAD 2.53 billion, up 21.00 percent. Akdital stock added 359 beds and net income rose 20.00 percent in the first half of 2026.

Expansion and earnings timeline

Akdital completed its Mecca hospital acquisition for a 126-bed facility on September 21, 2026.
First-half 2026 revenue reached MAD 2.53 billion, up 21.00 percent year over year.
Akdital is scheduled to publish its next results on December 2, 2026.

AKT, MA0000012585, Illustration mit AI erstellt.

Akdital (ISIN MA0000012585) completed its acquisition of a majority stake in Mecca's Al Bishri Hospital on September 21, 2026, while analysts put a 12-month target of MAD 1,680.00 on Akdital stock. 7News Morocco reported that the facility will expand from 120 to 126 beds, and Investing.com listed the average analyst target at MAD 1,680.00.

Three dated operating milestones

On September 21, 2026, the Mecca transaction gave Akdital a second Saudi facility after its Riyadh launch, with the hospital planned at 126 beds. The deal adds an international growth leg to a Moroccan network that 7News Morocco described as 45 facilities across 26 cities, with 4,864 beds and 10,256 employees.

On September 30, 2026, Le360 reported consolidated revenue of MAD 2.53 billion for the first half of 2026, up 21.00 percent from the same period of 2025. Consolidated net income rose 20.00 percent to MAD 252.00 million, while EBITDA increased 19.00 percent to MAD 634.00 million and the net margin held at 10.00 percent.

The same results release said Akdital added 359 beds during the first half, taking the network to 45 establishments and 4,864 beds. The expansion came with MAD 875.00 million of first-half investment, including MAD 477.00 million directed to projects in Saudi Arabia and the United Arab Emirates. Net debt reached MAD 4.85 billion on June 30, 2026, up 14.00 percent from December 31, 2025.

What does the expansion mean?

The figures point to a growth model that combines new capacity with rising hospital utilization. First-half admissions increased 15.00 percent to 590,842, while oncology contributed 36.00 percent of semiannual revenue, compared with 31.00 percent a year earlier, according to Le360.

Market activity supplied a separate signal on October 12, 2026. TelQuel reported that Akdital represented 68.20 percent of weekly activity in the healthcare segment, with MAD 58.30 million traded across 57,144 shares and 1,699 transactions during the week of October 5, 2026.

Next results date

Investing.com lists December 2, 2026 as Akdital's next results date. On October 13, 2026, the stock was last quoted at MAD 1,070.00 on the Casablanca Stock Exchange, against a 52-week range of MAD 975.00 to MAD 1,484.00 and a market capitalization of MAD 15.01 billion.